@article{6a8c4731538f4e89bd63acf30d2abf52,
title = "Infliximab, azathioprine, or combination therapy for Crohn's disease",
abstract = "The comparative efficacy and safety of infliximab and azathioprine therapy alone or in combination for Crohn's disease are unknown.",
keywords = "Adrenal Cortex Hormones, Adult, Anti-Inflammatory Agents, Antibodies, Monoclonal, Azathioprine, Chi-Square Distribution, Crohn Disease, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Immunosuppressive Agents, Infusions, Intravenous, Logistic Models, Male, Remission Induction",
author = "Colombel, \{Jean Fr{\'e}d{\'e}ric\} and Sandborn, \{William J\} and Walter Reinisch and Mantzaris, \{Gerassimos J\} and Asher Kornbluth and Daniel Rachmilewitz and Simon Lichtiger and Geert D'Haens and Diamond, \{Robert H\} and Broussard, \{Delma L\} and Tang, \{Kezhen L\} and \{van der Woude\}, \{C Janneke\} and Paul Rutgeerts and NN NN",
note = "2010 Massachusetts Medical Society",
year = "2010",
doi = "10.1056/NEJMoa0904492",
language = "English",
volume = "362",
pages = "1383--95",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "15",
}